UBA6 and neoplasm: Our results revealed that UBA6 deletion, among the 23 identified genes, had the highest negative score which indicates the increased sensitivity of tumour cells to immune attack in vivo (Supplementary Fig. 4d), consistent with the results from several CRISPR genetic screen data sets (Fig. 3d and Supplementary Fig. 4b, c).